- Home
- MTCH vs ICLR Comparison
MTCH vs ICLR Comparison
Compare MTCH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | ICLR |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.2B |
| IPO Year | 2003 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MTCH | ICLR |
|---|---|---|
| Price | $34.78 | $115.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $35.00 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 3.3M | 766.1K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.32% | N/A |
| EPS Growth | ★ 17.82 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $3,487,197,000.00 | N/A |
| Revenue This Year | $2.26 | N/A |
| Revenue Next Year | $3.90 | N/A |
| P/E Ratio | $14.53 | ★ $12.91 |
| Revenue Growth | ★ 0.22 | N/A |
| 52 Week Low | $26.80 | $66.57 |
| 52 Week High | $39.20 | $211.00 |
Technical Indicators
Market Signals| Indicator | MTCH | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 57.54 |
| Support Level | $31.45 | $102.53 |
| Resistance Level | $39.01 | $155.58 |
| Average True Range (ATR) | 0.92 | 4.98 |
| MACD | 0.38 | 1.85 |
| Stochastic Oscillator | 94.74 | 79.26 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. It generates the majority of its revenue from the Tinder segment.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.